GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocular Therapeutix Inc (NAS:OCUL) » Definitions » Cyclically Adjusted PB Ratio

Ocular Therapeutix (Ocular Therapeutix) Cyclically Adjusted PB Ratio : 3.51 (As of Apr. 29, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Ocular Therapeutix Cyclically Adjusted PB Ratio?

As of today (2024-04-29), Ocular Therapeutix's current share price is $4.885. Ocular Therapeutix's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $1.39. Ocular Therapeutix's Cyclically Adjusted PB Ratio for today is 3.51.

The historical rank and industry rank for Ocular Therapeutix's Cyclically Adjusted PB Ratio or its related term are showing as below:

OCUL' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.77   Med: 5.75   Max: 9.91
Current: 3.41

During the past years, Ocular Therapeutix's highest Cyclically Adjusted PB Ratio was 9.91. The lowest was 2.77. And the median was 5.75.

OCUL's Cyclically Adjusted PB Ratio is ranked worse than
69.73% of 641 companies
in the Biotechnology industry
Industry Median: 1.74 vs OCUL: 3.41

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Ocular Therapeutix's adjusted book value per share data for the three months ended in Dec. 2023 was $0.793. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.39 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Ocular Therapeutix Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Ocular Therapeutix's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocular Therapeutix Cyclically Adjusted PB Ratio Chart

Ocular Therapeutix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 3.71 3.20

Ocular Therapeutix Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.71 6.99 6.94 4.28 3.20

Competitive Comparison of Ocular Therapeutix's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Ocular Therapeutix's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ocular Therapeutix's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocular Therapeutix's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Ocular Therapeutix's Cyclically Adjusted PB Ratio falls into.



Ocular Therapeutix Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Ocular Therapeutix's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=4.885/1.39
=3.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ocular Therapeutix's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Ocular Therapeutix's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.793/129.4194*129.4194
=0.793

Current CPI (Dec. 2023) = 129.4194.

Ocular Therapeutix Quarterly Data

Book Value per Share CPI Adj_Book
201403 0.542 99.695 0.704
201406 -6.990 100.560 -8.996
201409 3.077 100.428 3.965
201412 2.751 99.070 3.594
201503 2.430 99.621 3.157
201506 4.414 100.684 5.674
201509 3.995 100.392 5.150
201512 3.620 99.792 4.695
201603 3.238 100.470 4.171
201606 2.838 101.688 3.612
201609 2.504 101.861 3.181
201612 2.078 101.863 2.640
201703 2.209 102.862 2.779
201706 1.653 103.349 2.070
201709 1.222 104.136 1.519
201712 0.882 104.011 1.097
201803 1.319 105.290 1.621
201806 1.188 106.317 1.446
201809 1.123 106.507 1.365
201812 0.864 105.998 1.055
201903 0.599 107.251 0.723
201906 0.187 108.070 0.224
201909 0.235 108.329 0.281
201912 -0.072 108.420 -0.086
202003 -0.201 108.902 -0.239
202006 0.085 108.767 0.101
202009 -0.065 109.815 -0.077
202012 1.001 109.897 1.179
202103 1.094 111.754 1.267
202106 1.050 114.631 1.185
202109 1.140 115.734 1.275
202112 1.147 117.630 1.262
202203 1.040 121.301 1.110
202206 0.856 125.017 0.886
202209 0.600 125.227 0.620
202212 0.458 125.222 0.473
202303 0.125 127.348 0.127
202306 0.039 128.729 0.039
202309 0.099 129.860 0.099
202312 0.793 129.419 0.793

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ocular Therapeutix  (NAS:OCUL) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Ocular Therapeutix Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Ocular Therapeutix's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ocular Therapeutix (Ocular Therapeutix) Business Description

Traded in Other Exchanges
Address
24 Crosby Drive, Bedford, MA, USA, 01730
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Executives
Summer Road Llc 10 percent owner 207 6TH STREET, WEST PALM BEACH FL 33401
Antony C. Mattessich director C/O OCULAR THERAPEUTIX, INC., 34 CROSBY DR., SUITE 105, BEDFORD MA 01730
Adrienne L Graves director 125 STONE MOUNTAIN CIRCLE, NAPA CA 94558
Rabia Gurses Ozden officer: Chief Medical Officer C/O AKOUOS, INC., 645 SUMMER STREET SUITE 200, BOSTON MA 02210
Philip C. Strassburger officer: General Counsel 24 CROSBY DRIVE, BEDFORD MA 01730
Donald Notman officer: Chief Financial Officer C/O OCULAR THERAPEUTIX, INC., 15 CROSBY DRIVE, BEDFORD MA 01730
Christopher G White officer: Chief Business Officer C/O AMAG PHARMACEUTICALS, INC., 1100 WINTER STREET, WALTHAM MA 02451
Jeffrey S. Heier director C/O OCULAR THERAPEUTIX, INC., 34 CROSBY DR., SUITE 105, BEDFORD MA 01730
Merilee Raines director IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Lindstrom Richard L Md director 2811 WESTWOOD PL, WAYZATA MN 55391
Opaleye Management Inc. 10 percent owner ONE BOSTON PLACE, SUITE 2600, BOSTON MA 02108
Patricia Kitchen officer: Chief Operations Officer C/O OCULAR THERAPEUTIX, INC., 15 CROSBY DRIVE, BEDFORD MA 01730
Leslie J. Williams director C/O OCULAR THERAPEUTIX, INC., 15 CROSBY DRIVE, BEDFORD MA 01730
Seung Suh Hong director C/O OCULAR THERAPEUTIX, INC., 15 CROSBY DRIVE, BEDFORD MA 01730
Amarpreet Sawhney director, 10 percent owner, officer: President and CEO C/O OCULAR THERAPEUTIX, INC., 36 CROSBY DRIVE, SUITE 101, BEDFORD MA 01730

Ocular Therapeutix (Ocular Therapeutix) Headlines

From GuruFocus